USPTO serial 79001685
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
D-14513 Teltow, DE
D-14513 Teltow, DE
D-14513 Teltow, DE
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals and biochemicals for use in the manufacture of tissue engineering based products, somatic cell therapeutics, and cell based products for regenerative medicine; biocatalysts for use in the manufacture of industrial chemicals | SECTION 71 - CANCELLED | — |
| 005 | Medical and veterinary preparations and substances for the treatment of skeletal diseases, diseases of the connective tissue, neurological diseases, urological diseases, dermatological diseases, liver diseases and auto-immune diseases, heart or circulation diseases; products and substances for medical and veterinary purposes produced or modified by genetic engineering, namely, cells, proteins, growth factors, cytokines, hormones, antibodies, enzymes, all for use in the treatment of coronary heart disease, atherosclerosis, vascular injuries, cartilage damage, bone damage, wound healing, regeneration of nerves and spinal cords, bladder or urethra damage, skin repair, and autoimmune liver diseases; biological materials intended for subsequent implantation, namely, endothelial cells, muscle cells, connective tissue, blood vessels, cells, organ transplants and implants, tissue transplants and implants; biochemicals for medical purposes, namely cell culture media, carriers for cell cultures, nutrient media, cytokines, hormones, signal transduction molecules, antibodies, nucleotides, ribonucleotides, primers, enzymes, proteins and growth factors; diagnostic agents for medical use; endothelial cell transplants and implants; organ transplants and implants composed of biological materials, tissue transplants and implants composed of biological materials; biological resorbent and non-resorbent substrates in combination with endothelial cell transplants; coated materials with endothelial cells and/or in combination with muscle and connective tissue cells for use in transplantation; biological resorbent and non-resorbent substances in combination with endothelial cell and vessel cell transplants | SECTION 71 - CANCELLED | — |
| 010 | Medical and surgical apparatus and instruments, namely endoscopical devices; implants consisting of artificial materials, artificial tissue and tissue replacement for medical purposes | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2013 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jun 30, 2013 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 30, 2012 | C71T | CANCELLED SECTION 71 | — |
| Oct 5, 2007 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 19, 2006 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 19, 2006 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 12, 2006 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 22, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 30, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 10, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| May 3, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 29, 2005 | ALIE | ASSIGNED TO LIE | — |
| Apr 25, 2005 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 22, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 7, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 14, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2005 | PAPER RECEIVED | — | |
| Mar 4, 2005 | FAXX | FAX RECEIVED | — |
| Oct 7, 2004 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 8, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 21, 2004 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |